D
DMRA
DAMORA THERAPEUT
21.09
-0.62-2.86%Closed19:30 10/23 EDT
OPEN/PREV CLOSE21.19/21.09
TODAY RANGE21.09-21.78
VOL411.11K
MARKET CAP1.31B
52 WEEK RANGE4.950-38.33
AVG VOL (3M)522.36K
% TURNOVER0.67%
TURNOVER--
P/E (TTM)-0.1524
% RANGE3.27%
EPS(TTM)-139.3426
P/E(FORWARD)-10.6068
P/B2.540
BVPS8.36
DIVIDEND--
P/S4.070
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.17B
SHARES OUTSTANDING61.74M
NEXT EARNINGS11/04-11/09
FREE FLOAT55.31M
LOT SIZE1
EX-DATE08/30/2024
News
Press Releases
Financial Reports
Profile
Benzinga·5d ago
Winnebago Industries Posts Upbeat Q4 Earnings, Joins SpaceX, Super Micro Computer And Other Big Stocks Moving Higher On Wednesday
TipRanks·09/30 16:31
Damora Therapeutics Advances CALR-Targeted Antibody Into Early Clinical Testing
Dow Jones·09/29 12:30
Damora Therapeutics Price Target Maintained With a $40.00/Share by Wedbush
Benzinga·09/29 12:20
Wedbush Reiterates Outperform on Damora Therapeutics, Maintains $40 Price Target
TipRanks·09/29 02:00
Top Executive Makes Bold Insider Move at Damora Therapeutics
Dow Jones·09/25 13:14
Damora Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones·09/25 13:14
Damora Therapeutics Price Target Raised to $60.00/Share From $40.00 by Guggenheim
Benzinga·09/25 13:04
Guggenheim Maintains Buy on Damora Therapeutics, Raises Price Target to $60
TipRanks·09/25 12:15
Damora Therapeutics price target raised, named a Best Idea at Guggenheim
Seeking Alpha·09/15 11:05
Damora Therapeutics: Potential Payday Is A Long Way Off
NASDAQ·09/03 12:33
Damora Therapeutics Grants Inducement Awards To Three New Employees
Seeking Alpha·08/12 17:03
Damora Therapeutics: Competition Validates The Target While Its Portfolio Creates The Upside
Same Industry
Name/Symbol
Change%
Price